Latest Nanoform News & Updates

See the latest news and media coverage for Nanoform. We track all announcements, press releases, and industry mentions in real time, all in one place.

Nanoform

Nanotechnology drug particle engineering services provider

nanoform.com

Headquarters: Helsinki, Finland
Founded year: 2015
Company type: Public company
Number of employees: 100–200
Industry: Medical Equipment, Supplies & Distribution

Last updated Today

Latest news about Nanoform

In short: Nanoform achieved record revenues, signed a major biologics deal, and received positive UK regulatory feedback for nanoenzalutamide.

Company announcements

August 20 Nanoform

Nanoform reports Q2 2026 financials and regulatory progress

Revenue grew 33% while operating costs fell significantly. The company initiated sterile GMP manufacturing discussions and received positive UK MHRA feedback for nanoenzalutamide.

August 5 Nanoform

Nanoform received positive UK MHRA scientific advice for nanoenzalutamide

The agency supports pursuing a hybrid marketing authorization application using existing bioequivalence studies and pharmacokinetic modelling.

May 29 Nanoform

Nanoform issues stock options to key individuals

The options are free of charge with a subscription price of EUR 1.70 per share, totaling up to 420,000 shares.

May 19 Nanoform

Nanoform reports record Q1 revenue and gross margin

Revenue grew 45% to EUR 1.3m, gross margin 94%, and first biologics exclusivity deal signed.

Media coverage

August 19 Investing.com

Earnings Call: Nanoform reduces cash burn in Q2 2026 and achieves regulatory progress

Nanoform announced that it has significantly reduced cash burn in the second quarter of 2026 and achieved progress with its programs for small-molecule drugs as well as biologics. To...

August 5 Kauppalehti

Inside information: Positive Feedback from UK MHRA Scientific Advice Meeting regarding Nanoenzalutamide

Christian Jones, Chief Commercial Officer of Nanoform, commented...

July 22 Yahoo Finance

Nanoform Finland Oyj (NANOFH.HE) Q3 FY2025 earnings call transcript

Earnings call Nanoform achieved a major milestone by securing a commercial GMP manufacturing license, enabling sales of nanoformed APIs in Europe and other key markets...

May 31 Kauppalehti

The 'Pharma Tesla' of the Helsinki Stock Exchange got a blockbuster deal - CEO: Huge news

Medical technology company Nanoform signed an agreement with a US company. The good news is overshadowed by the sufficiency of funding and the delay in the company's drug marketing authorization application. "You don't have to wait long," the CFO says ...

Never miss news about Nanoform

Track Nanoform and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Nanoform competitors & trending companies

Browse news for competitors to Nanoform and other trending companies.